Evidence map›Paper›PMID 32844591›Full record

ArticleJournal of the International AIDS Society2020

The importance of PrEP persistence in preventing HIV infections on PrEP.

Matthew A Spinelli, Nicole Laborde, Patrick Kinley, Ryan Whitacre, Hyman M Scott, Nicole Walker, Albert Y Liu, Monica Gandhi, Susan P Buchbinder

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. The importance of PrEP persistence in preventing HIV infections on PrEP.Journal of the International AIDS Society · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Matthew A SpinelliDivision of HIV, ID, and Global Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0001-6368-8664
Nicole LabordeSan Francisco Department of Public Health, San Francisco, CA, USA.
Patrick KinleySan Francisco Department of Public Health, San Francisco, CA, USA.
Ryan WhitacreDepartment of Anthropology and Sociology, The Graduate Institute Geneva, Geneva, Switzerland.
Hyman M ScottSan Francisco Department of Public Health, San Francisco, CA, USA.
Nicole WalkerSan Francisco Department of Public Health, San Francisco, CA, USA.
Albert Y LiuSan Francisco Department of Public Health, San Francisco, CA, USA.
Monica GandhiDivision of HIV, ID, and Global Medicine, University of California, San Francisco, CA, USA.
Susan P BuchbinderSan Francisco Department of Public Health, San Francisco, CA, USA.

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention TrialsR01AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GANDHI, MONICA · 2012 to 2021
$5.6M
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)R01AI143340 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2018 to 2026
$5.6M
DOT Diary (D2): Developing a mobile app with combined automated DOT and daily sexual diary for monitoring and improving PrEP adherenceR01MH109320 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI BUCHBINDER, SUSAN · 2015 to 2018
$3.9M
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.R37AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2023 to 2026
$3.2M
PrEP Point-of-Care Brief-Intervention for Adherence among Young Men Who Have Sex with Men (PrEP2-BAY Study)K23MH122286 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPINELLI, MATTHEW A. · 2020 to 2024
$1.0M
NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI143340NIAID NIH HHS R01AI143340NIAID NIH HHS R37 AI098472NIAID NIH HHS T32 AI060530NIAID NIH HHS UM1 AI069496NIMH NIH HHS K23 MH122286NIMH NIH HHS K23MH122286NIMH NIH HHS R01 MH109320NIMH NIH HHS R01MH109320
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHumansMedication AdherenceSan FranciscoUnited StatesAnti-HIV AgentsadherenceHIV seroconversionmixed methodsPrEPPrEP discontinuationPrEP persistence

Identifiers

PMID32844591
PMCPMC7448189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.